opaque tape-without SSc application SSc (-) . SSc was applied approximately 20 minutes before the opaque tape was applied. SPF 50 + SSc containing organic and inorganic filters against UVA-UVB (Solante; Buergli Pharma, Inc., Makati, Philippines) was used. Dermoscopic images of the selected MN were captured with a digital dermoscopy system at the beginning, at the end, and 3-6 months after the end of NBUVB therapy. At all follow-ups, total body mole mapping was performed with a fully automated body mole-mapping programme (Body Studio ATBM; FotoFinder Systems Inc, Columbia, MD, USA). Dermoscopic photographing, total body mole mapping, and arrangement of photographs were performed by one researcher (DÖK). The evaluation of the images was done by another researcher (NK) without knowing whether the lesion was SSc(+) or SSc(-). The MN that showed unexpected dermoscopic findings, such as decrease in size or loss of structure, were further evaluated by another researcher (IKK).
The data were analyzed with the SPSS Statistics 21 packet programme. Sustained variables were given as average ± standard deviation, minimum -maximum assets and categorical variables for numbers and percentages. In order to compare the independent group discrepancies, the Mann-Whitney U test was used. The differences between categoric variables were examined with Chi-square test. For examination of risk factors, the logistic regression test was used.
Results
Of the 24 patients enrolled, a total of 165 MN were identified.
Excluded from the study were 6 patients with 34 MN, who were lost to follow-up and 11 MN of included patients that had poor image quality. In sum, the study included 120 MN belonging to 18 patients (mean age: 44.7±14.2 years; 13 women).
The majority of patients were diagnosed with mycosis fungoides (n:5; 27.8%) and psoriasis (n:5; 27.8%); the remaining diagnoses were pruritus, granuloma annulare, pityriasis lichenoides chronica and perforating dermatoses. Fitzpatrick skin type 3 was the most common skin type (n:14; 77.8%). 
Materials and Methods
All patients with a variety of dermatologic diseases were Table 2 ).
The ratio of SSc(+) MN that showed darkening pigmentation, darkening pigment network, increase in size, and decrease in the number of dot and/or globules were higher than SSc(-) MN (p>0.05) ( Table 3) . and UVA2 both induce MN development [11, 12] . Epidemiological and twin studies revealed a relationship between the number of MN and the intermittant intense UV exposure; however, no relationship was established between daily UV exposure and MN number [13, 14] . It was shown that as the experienced sunburn number and severity increase, new MN or had a tendency to do so (Table 4 , Figure 2 ). The dermoscopic changes and histopathologic results of excised MN are summarized in Table 5 .
Before starting the study, it was calculated with 80%
power that 95% confidence could be achieved if 49 MN would be included in each group (at least 98 MN) when power analysis had been performed, assuming the obtainable ratios would be 10% and 30%. When the results of the study were examined, power analysis was performed according to these results [for size decrease SSc(+) 9.6% vs SSC(-) 33.8%, and for structure loss SSC(+) 3.8% vs. SSC(-) 19 .1%], and it was determined that the present study had 95% and 86%
power, respectively, with 95% confidence. treatment [16, 17] and even in 43.2% of covered MN during psoralen-ultraviolet A (PUVA) and NBUVB treatment [7] . We observed dermoscopic changes in most of the MN (65%) despite being covered with opaque tape in all and with SSc in half of them. Higher ratios that are found in our study may be related to the detailed dermoscopic evaluation parameters.
TABLE 2. More frequently observed dermoscopic changes in SSc(-) MN compared to SSc(+) MN at the beginning vs. end of NBUVB therapy** (n=120)

SSc(+); n (%) SSc(-); n (%) P
Lin et al recognized size changes in a larger proportion of the MN located on the abdominal region in comparison to the MN located on other body sites but noted no significant relation with skin type [16] . In our study, we did not detect any differences in dermoscopic changes between SSc(+) and SSc(-) MN groups according to anatomical location.
Kılınç Karaaslan et al observed increase in size in uncovered MN but not in opaque tape-covered MN at the end of development increases [15] . These findings explain that the nevogenic effect of UV is dose dependent and is distinctive in areas where environmental UV is much more intense. We did not observe new MN development in our study. It can be related to other factors, including that almost all our patients were dark phenotype, all were over 18 years old, and we had short-term follow-up. In addition, the ones who had severe sunburn history were excluded from the study, and during treatment the UV dosage were raised gradually.
There are genetic factors that have not been identified, yet might have a role.
UV light can cause clinical, histopathologic and dermoscopic changes in MN by increasing melanin synthesis or inducing melanocyte proliferation [3] [4] [5] . Dermoscopic changes were reported in 27-50% of MN during NBUVB * %total [%SSc(+): %SSc(-)]; these ratios were calculated within 42 MN that were reexamined after discontinuing therapy NBUVB, UVA1 and PUVA treatments for three months [17] .
None of the above studies mention decrease in size in MN and it was not stated whether size decrease was taken into consideration.
Lin et al detected size change in 40% of MN during NBUVB treatment, and similar to our study, they evaluated MN size in terms of both decrease and increase. They a mean 9 weeks of NBUVB treatment [8] . Similarly to their observation, Ghani-Nejad et al determined a significant increase in size in uncovered MN, but not in opaque tapecovered MN, after NBUVB treatment for 30-60 sessions [7] .
Contrary to these studies, Karaca et al established a statistically significant mean area measurement increase in MN, despite being uncovered, in patient groups who received observed size decrease and increase in 54% and 46% of MN that displayed size change, respectively [16] .
Dobrosavljevic et al evaluated dermoscopic changes in
MN of patients using and not using SSc 28 days after UV exposure for a minimum of 7 days. They did not detect any significant change in MN in terms of size increase between the two groups. However, 28 days after the end of UV exposure they observed that the fading in pigmentation in a large proportion of MN belonged to the group that was not using SSc compared to other group who was using SSc (61.9% vs.
20.5%, respectively) [18] .
In our study, we detected size change in the 27.5% of MN, 84.8% of which showed decrease in size. The ratios of MN that showed size decrease and structure loss were statistically significantly higher in the SSc(-) group compared to the SSc(+) group. In addition, we also found the ratios of MN that showed fading in pigmentation network and in pigmentation were also higher in the SSc(-) group, although the difference did not reach a statistically significant level.
We excised one of the MN that showed size decrease, fading in pigmentation, and pigmentation network, but no other dermoscopic change, and we did not detect atypical histopathologicafindings. We thought that the above-mentioned dermoscopic findings might have emerged by induction of melanocyte apoptosis and blockage of melanin production from melanocytes by NBUVB [19, 20] . According to our findings, it can be speculated that SSc application in combination with opaque tape may hinder the triggering effects of NBUVB over MN involution.
Hofmann-Wellenhof et al detected significant darkening in brown color and total irregularity generation in uncovered MN during UVB treatment but no significant dermoscopic changes in those covered by opaque tape. However, when considering MN covered and uncovered with opaque tape together, they recognized that MN showed significantly more "total irregularity," darker "brown color," and increase in brown globules and pigment network width at the end of UVB treatment compared to the beginning. In all, they thought these changes may depend on the systemic effects of UV radiation on MN [5] . The emergence of dermoscopic changes in the majority of MN during our study, despite being covered with opaque type, supports the systemic effects of UV on MN.
Kılınç Karaaslan et al established that the majority of dermoscopic changes arising after NBUVB and PUVA treatments were reversible [8] . Lin et al observed that while enlarged MN after NBUVB treatment tended to revert to pretreatment size 3 months after the cessation of therapy, the trend for MN showing size decrease was for continued size reduction [16] .
The majority of dermoscopic changes occured in our study showed a tendency to return to their former state at approximately a mean of 4.2 months after cessation of
